FLUENT Corp. (CSE: FNT.U; OTCQB: CNTMF) on Friday said it has entered into a definitive agreement to sell its Texas business, including cultivation, manufacturing, delivery and retail operations, to Legacy Therapeutics for $30 million. Under the deal, $25 million will be paid at closing, with two additional $2.5 million payments due on the first and […]
Source link
You May Also Like
Breaking News
Federal Drug Policy, April 2026: The Operative Architecture of Cannabis Rescheduling, the Psychedelic Therapeutic Acceleration Directive, and the Road to June 29 RN...
cannabis business
As the end of November approaches you can feel the buzz amongst cannabis industry circles about the yearly pilgrimage we all make to Las...
autoflower seeds
Autoflowering cannabis has entered a new era. Thanks to years of focused breeding, modern autoflowers now rival traditional photoperiod strains in terpene intensity, trichome...
2026
May usually rolls in with sparkly vibes of sunshine and flowers. Beach days hover on the horizon, and the energy of the month embodies...